Acute Respiratory Distress Syndrome (ARDS)Symptoms, Doctors, Treatments, Advances & More
Acute Respiratory Distress Syndrome (ARDS) Overview
Learn About Acute Respiratory Distress Syndrome (ARDS)
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
University Anesthesia Medical Group
Dr. Carolyn S. Calfee is a pulmonologist who cares for patients in UCSF's intensive care units. Calfee's research focuses on the causes and treatment of acute respiratory distress syndrome (ARDS). Her projects include studying the biologic differences within ARDS and how to target those differences by personalizing treatment; the role of environmental exposure, including to cigarette smoke and air pollution, in susceptibility to lung injury; and novel treatments for ARDS. During the coronavirus pandemic, she led research at UCSF to investigate how the immune system responds to COVID and to test promising new treatments for COVID-19-associated ARDS. Calfee earned her medical degree from the University of Pennsylvania Perelman School of Medicine. At UCSF, she completed a residency in internal medicine, serving as chief resident, followed by a fellowship in pulmonary and critical care medicine. She also earned a master of advanced study degree in clinical research at UCSF. She joined the UCSF faculty in 2007 and is a member of the UCSF Center for Tobacco Control Research and Education. Dr. Calfee is rated as an Elite provider by MediFind in the treatment of Acute Respiratory Distress Syndrome (ARDS). She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Acute Respiratory Distress Syndrome (ARDS), COVID-19, Pneumonia, Severe Acute Respiratory Syndrome (SARS), and Lung Transplant. Dr. Calfee is board certified in American Board Of Internal Medicine, Critical Care Medicine and American Board Of Internal Med/Pulmonary Disease, Pulmonary Disease.
Penn Heart And Vascular Center
Nuala Meyer is a Pulmonary Medicine provider practicing medicine in Philadelphia, Pennsylvania. Dr. Meyer is rated as an Elite provider by MediFind in the treatment of Acute Respiratory Distress Syndrome (ARDS). She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Acute Respiratory Distress Syndrome (ARDS), COVID-19, Severe Acute Respiratory Syndrome (SARS), Lung Transplant, and Gastrostomy. Dr. Meyer is board certified in Critical Care Medicine, 2008 and Pulmonary Disease, 2007. Dr. Meyer is currently accepting new patients.
Taubman Center
Dr. Sjoding is a member of the Division of Pulmonary and Critical Care at the University of Michigan. He received a degree in Biochemistry from Valparaiso University in Indiana, and a medical degree from Loyola Stritch School of Medicine in Chicago. He completed his internal medicine residency at the University of Chicago.Dr. Sjoding’s health services research interests concern pulmonary and critical care and hospital medicine, with a focus on inpatient hospital quality measures and their unintended consequences, the epidemiology of critical illness, and methods for critical care delivery. He is also interested in leveraging “Big Data” to enhance critical care research and care, and health service research methods including the use of both clinical and large-scale administrative databases, statistical simulation, causal analysis, and multi-level modeling. Dr. Sjoding is rated as an Elite provider by MediFind in the treatment of Acute Respiratory Distress Syndrome (ARDS). He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Acute Respiratory Distress Syndrome (ARDS), Cerebral Hypoxia, Chronic Obstructive Pulmonary Disease (COPD), and Pneumonia.
Summary: Spontaneous breathing during the transition from controlled to assisted ventilation in ARDS may be harmful, as high respiratory drive can generate large transpulmonary pressure swings and worsen lung injury. Higher PEEP may mitigate this by reducing inspiratory effort and lung stress, but patient response is variable and difficult to predict. While improved lung compliance appears to mediate the p...
Summary: This is a phase I trial followed by a phase II randomized trial. The purpose of phase I study is the feasibility of treating patients with acute respiratory distress syndrome (ARDS) related to COVID-19 infection (COVID-19) with cord blood-derived mesenchymal stem cells (MSC). The purpose of the phase II trial is to compare the effect of MSC with standard of care in these patients. MSCs are a type ...


